Literature DB >> 10898750

Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice.

D M McCafferty1, E Sihota, M Muscara, J L Wallace, K A Sharkey, P Kubes.   

Abstract

Mice deficient in both inducible nitric oxide synthase (iNOS) and interleukin (IL)-10 (iNOS(-/-)/IL-10(-/-)) were created to examine the role of iNOS in spontaneously developing intestinal inflammation. IL-10(-/-)/iNOS(-/-) mice were compared with IL-10(-/-) (iNOS(+/+)) littermates over 6 mo. RT-PCR, Western blot analysis, and immunohistochemistry were performed to measure iNOS message and protein levels. Plasma nitrate/nitrite (NO(x)) levels were assessed by HPLC. Damage scores (macroscopic and microscopic) and granulocyte infiltration were assessed. At 3-4 wk, IL-10(-/-) and IL-10(-/-)/iNOS(-/-) mice had no signs of colonic inflammation or granulocyte infiltration. Plasma NO(x) levels were not different from controls. By 3-4 mo, IL-10(-/-) mice had increased damage scores and granulocyte infiltration concurrent with increased mRNA and protein synthesis (restricted to the epithelium) for iNOS in intestinal tissues but not other tissues. Plasma NO(x) levels increased fivefold. Interestingly, in the absence of iNOS induction or increased plasma NO(x), iNOS(-/-)/IL-10(-/-) mice had damage and granulocyte infiltration equivalent to those observed in IL-10(-/-) littermates. These data suggest that iNOS does not impact on the development or severity of spontaneous chronic inflammation in IL-10-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898750     DOI: 10.1152/ajpgi.2000.279.1.G90

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  27 in total

Review 1.  Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.

Authors:  Aya M Westbrook; Akos Szakmary; Robert H Schiestl
Journal:  Mutat Res       Date:  2010-03-16       Impact factor: 2.433

2.  Protective effect of proteinase-activated receptor 2 activation on motility impairment and tissue damage induced by intestinal ischemia/reperfusion in rodents.

Authors:  Fiore Cattaruzza; Nicolas Cenac; Elisabetta Barocelli; Mariannina Impicciatore; Eric Hyun; Nathalie Vergnolle; Catia Sternini
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.

Authors:  Nicolas Cenac; Anne-Marie Coelho; Cathy Nguyen; Steven Compton; Patricia Andrade-Gordon; Wallace K MacNaughton; John L Wallace; Morley D Hollenberg; Nigel W Bunnett; Rafael Garcia-Villar; Lionel Bueno; Nathalie Vergnolle
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

4.  Colorectal carcinoma development in inducible nitric oxide synthase-deficient mice with dextran sulfate sodium-induced ulcerative colitis.

Authors:  Darren N Seril; Jie Liao; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2007-05       Impact factor: 4.784

Review 5.  Bacteria, inflammation, and colon cancer.

Authors:  Liying Yang; Zhiheng Pei
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

Review 6.  Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.

Authors:  George Kolios; Vassilis Valatas; Stephen G Ward
Journal:  Immunology       Date:  2004-12       Impact factor: 7.397

7.  Role of neuronal nitric oxide synthase and inducible nitric oxide synthase in intestinal injury in neonatal rats.

Authors:  Hui Lu; Bing Zhu; Xin-Dong Xue
Journal:  World J Gastroenterol       Date:  2006-07-21       Impact factor: 5.742

8.  Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis.

Authors:  Hongying Wang; Rui Zhang; Shoubin Wen; Donna-Marie McCafferty; Paul L Beck; Wallace K MacNaughton
Journal:  J Mol Med (Berl)       Date:  2009-02-24       Impact factor: 4.599

Review 9.  Chemistry meets biology in colitis-associated carcinogenesis.

Authors:  A Mangerich; P C Dedon; J G Fox; S R Tannenbaum; G N Wogan
Journal:  Free Radic Res       Date:  2013-10-04

10.  Therapeutic action and underlying mechanisms of a combination of two pentacyclic triterpenes, alpha- and beta-amyrin, in a mouse model of colitis.

Authors:  C E Vitor; C P Figueiredo; D B Hara; A F Bento; T L Mazzuco; J B Calixto
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.